MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2 trials expected by mid-August 2026 ...

I'm a Big Tech executive with ADHD and anxiety. Neurodivergence has its downsides, but I've turned my habits into strengths.

Wainwright Yu, a Big Tech executive, shares his journey with anxiety and ADHD, turning challenges into strengths throughout ...
Psychology Today

Frontotemporal Dementia: Language and Behavior Gone Awry

Frontotemporal dementia causes striking shifts in behavior, emotion, and communication—making loved ones seem like different ...
BMJ Open

Psychosocial factors associated with non-suicidal self-injury in Iranian adolescents and young adults: a scoping review protocol

Introduction Non-suicidal self-injury (NSSI) is defined as the deliberate harm to one’s body without suicidal intent. Although individuals engaging in NSSI do not intend to die, repetitive self-injury ...